2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …
M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
Assessment of Right Ventricular Function—a State of the Art
Abstract Purpose of Review The right ventricle (RV) has a complex geometry and physiology
which is distinct from the left. RV dysfunction and failure can be the aftermath of volume …
which is distinct from the left. RV dysfunction and failure can be the aftermath of volume …
Validation of artificial intelligence cardiac MRI measurements: relationship to heart catheterization and mortality prediction
S Alabed, F Alandejani, K Dwivedi, K Karunasaagarar… - Radiology, 2022 - pubs.rsna.org
Background Cardiac MRI measurements have diagnostic and prognostic value in the
evaluation of cardiopulmonary disease. Artificial intelligence approaches to automate …
evaluation of cardiopulmonary disease. Artificial intelligence approaches to automate …
Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of …
M Humbert, G Kovacs, MM Hoeper… - … : 2022 ESC/ERS …, 2023 - produccioncientifica.ucm.es
Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …
[HTML][HTML] Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements
Background Right atrial (RA) area predicts mortality in patients with pulmonary
hypertension, and is recommended by the European Society of Cardiology/European …
hypertension, and is recommended by the European Society of Cardiology/European …
Imaging and risk stratification in pulmonary arterial hypertension: time to include right ventricular assessment
F Alandejani, A Hameed, E Tubman… - Frontiers in …, 2022 - frontiersin.org
Background Current European Society of Cardiology and European Respiratory Society
guidelines recommend regular risk stratification with an aim of treating patients with …
guidelines recommend regular risk stratification with an aim of treating patients with …
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
DG Kiely, R Condliffe - European Respiratory Journal, 2021 - Eur Respiratory Soc
Managing patients with pulmonary hypertension (PH) in association with chronic lung
disease and/or hypoxia (PH-CLD) remains one of the most challenging areas in pulmonary …
disease and/or hypoxia (PH-CLD) remains one of the most challenging areas in pulmonary …
Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension
Background Cardiac magnetic resonance (CMR) is the gold standard technique to assess
biventricular volumes and function, and is increasingly being considered as an end-point in …
biventricular volumes and function, and is increasingly being considered as an end-point in …
Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIR
Background Measures that can detect large treatment effects are important for monitoring
therapeutic effectiveness. The 2022 European Society of Cardiology/European Respiratory …
therapeutic effectiveness. The 2022 European Society of Cardiology/European Respiratory …
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and …
F Varian, J Dick, C Battersby, S Roman… - Pulmonary …, 2024 - Wiley Online Library
Approved therapies for the treatment of patients with pulmonary arterial hypertension (PAH)
mediate pulmonary vascular vasodilatation by targeting distinct biological pathways …
mediate pulmonary vascular vasodilatation by targeting distinct biological pathways …